Filing Details
- Accession Number:
- 0001209191-12-041038
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-08 21:46:25
- Reporting Period:
- 2012-08-06
- Filing Date:
- 2012-08-08
- Accepted Time:
- 2012-08-08 21:46:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1012140 | Onyx Pharmaceuticals Inc | ONXX | Biological Products, (No Disgnostic Substances) (2836) | 943154463 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1225509 | M Suzanne Shema | C/O Onyx Pharmaceuticals, Inc. 249 East Grand Ave. South San Francisco CA 94080 | Evp, General Counsel & Sec | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-08-06 | 6,550 | $71.93 | 44,118 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-08-07 | 656 | $30.28 | 44,774 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-08-07 | 1,344 | $32.07 | 46,118 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-08-07 | 2,100 | $37.68 | 48,218 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-08-07 | 12,833 | $35.18 | 61,051 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-08-07 | 2,000 | $71.79 | 59,051 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-08-07 | 14,933 | $71.97 | 44,118 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2012-08-07 | 656 | $0.00 | 656 | $30.28 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2012-08-07 | 1,344 | $0.00 | 1,344 | $32.07 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2012-08-07 | 2,100 | $0.00 | 2,100 | $37.68 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2012-08-07 | 12,833 | $0.00 | 12,833 | $35.18 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 13,125 | 2020-03-30 | No | 4 | M | Direct | |
| 28,909 | 2019-08-30 | No | 4 | M | Direct | |
| 25,900 | 2022-03-29 | No | 4 | M | Direct | |
| 25,667 | 2021-03-30 | No | 4 | M | Direct |
Footnotes
- The shares were sold at prices between $71.7744 and $72.054. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Shares sold pursuant to a 10b5-1 plan.
- The shares were sold at prices between $71.93 and $72.08. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- 12.5% of the shares subject to the option become exercisable 6 months following the date of grant. The remaining shares become exercisable in equal monthly installments over the following 42 months for a total vesting schedule of 48 months.
- Twenty-Five percent of the shares subject to the option vest and become exercisable one year from the date of grant and vest and become exercisable at a rate of 1/48th per month thereafter.
- The shares vest monthly from the date of grant at a rate of 1/48th per month over a period of 48 months.
Billionaire Hedge Funds
